Y Combinator

Y Combinator is a startup accelerator based in Mountain View, California, founded in 2005. It has pioneered a new funding model for early-stage startups by investing a modest amount of capital, typically around $150,000, in a large number of companies twice a year. Over a three-month program, Y Combinator collaborates closely with these startups to prepare them for investor pitches and enhance their business strategies. Each funding cycle concludes with Demo Day, where startups present to an exclusive audience of investors. Y Combinator focuses on various sectors, including business software, education, healthcare, and financial technology, among others. In addition to initial funding, it offers ongoing support through its extensive alumni network. Since its inception, Y Combinator has funded over 630 startups, contributing significantly to the entrepreneurial ecosystem in Silicon Valley and beyond.

Gustaf Alstromer

Group Partner

Matt Bogrand

Associate, YC Continuity Fund

Timothy Brady

Partner

Craig R. Cannon

Director of Marketing

Adora Cheung

Partner

Nic Dardenne

Principal

Aaron Epstein

Group Partner

Brad Flora

Group Partner

Jared Friedman

Managing Director, Software and Group Partner

Aaron Harris

Partner

Carolynn Levy

Partner

Bradford (Brad) Lightcap

Associate, YC Continuity

Kat Manalac

Managing Partner

Eric Migicovsky

Partner

Kirsty Nathoo

Partner

Verena Prescher

Director of Finance

Geoff Ralston

president

Ali Rowghani

Managing Partner

Arnav Sahu

Principal

Michael Seibel

Managing Director

Harj Taggar

Partner

Past deals in Health Diagnostics

Neurolytic Healthcare Ltd.

Pre Seed Round in 2022
Neurolytic Healthcare Ltd. is a company based in Oxford, United Kingdom, specializing in the design, development, manufacturing, and delivery of digital and genomic-based diagnostic tools and medical devices aimed at treating migraine and related neurological disorders. Established in 2016, the company focuses on personalized medicine by integrating genetic and biomarker data to enhance diagnostic accuracy and assist clinicians in determining optimal treatment strategies. Its product offerings include a diagnostic support tool, a pharmacogenetic test, and a mobile application designed for predicting migraine events. Through these innovative solutions, Neurolytic Healthcare aims to improve the management and treatment of neurological conditions.

Yemaachi Biotechnology

Seed Round in 2022
Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.

MedMe

Seed Round in 2022
MedMe Health is a patient care platform that assists pharmacists in scheduling, conducting, and tracking clinical services both virtually and on-site. The platform employs proprietary algorithms to streamline various medical services, including online scheduling, digital diagnosis, documentation filing, and automated follow-up appointments. By facilitating these processes, MedMe Health enables pharmacies to enhance their workflows, strengthen patient relationships, and diversify revenue opportunities within clinical services.

Athelas

Venture Round in 2022
Athelas, Inc. develops and manufactures an innovative in-home blood diagnostic device designed to monitor the immune system using just a drop of blood. Founded in 2016 and based in Mountain View, California, the company's portable optical unit analyzes blood cells and generates diagnostic reports. This technology assists healthcare providers in early identification of conditions such as leukemia, infections, and inflammatory diseases, allowing patients to monitor their immunity levels conveniently from home. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.
Medical company specialized in non invasive brain stimulation technologies for the treatment of neurological diseases.

Astek Diagnostics

Pre Seed Round in 2021
Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria

Yemaachi Biotechnology

Pre Seed Round in 2021
Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.

Examedi

Pre Seed Round in 2021
Examedi is a healthcare startup that provides nurse and lab technician services directly at patients' homes for appointments. Examedi connects the availabilities of healthcare providers with patients.

DocVita

Pre Seed Round in 2021
DocVita scales telehealth in India further with a platform that connects consumers with generalists and specialists across a wide network.

Tuli Health

Pre Seed Round in 2021
Tuli Health is a digital health platform that provides instant access to private medical appointments and testing.

Okani

Pre Seed Round in 2021
Okani is a digital health platform that provides accessible medical care services 24 hours a day. It offers care options with personal preferences in mind. They can deliver prescriptions and laboratory tests and, if necessary, they can also schedule patients with expert doctors in their city or nationwide.

Verano Health

Pre Seed Round in 2021
Verano Health is a digital tech nonprofit diabetes platform designed for undeserved patients fighting chronic disease. Verano Health reduces health disparities by providing Medicaid with personalized, culturally sensitive, and tech-enabled care

Parallel Bio

Pre Seed Round in 2021
Accelerating the discovery of immunotherapies

Neodocs

Pre Seed Round in 2021
NeoDocs Technologies Pvt. Ltd. provides personalized health and wellness services through the diagnostic report analyzer in the areas of thyroid, diabetes, liver diseases, heart conditions, and renal functions. It allows users to upload lab test results; receive personalized reports and recommendations; and implement suggestions and track health levels. The company was incorporated in 2020 and is based in Mumbai, India.

Known Medicine

Seed Round in 2021
Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.

Centaur Labs

Series A in 2021
Our platform uses trained professionals to analyze medical images and videos, enabling our customers to build new technologies and treatments to detect and fight disease.

Moichor

Seed Round in 2021
Moichor, vet healthcare, aims to empower veterinarians to accurately diagnose patients through data-driven approaches leading to drastically improved outcomes.

Dashlabs.ai

Seed Round in 2021
Dashlabs.ai is a developer of laboratory-based software that aims to enhance access to healthcare by automating laboratory tests and streamlining lab management processes. The company employs proprietary artificial intelligence and machine learning technologies to create solutions compatible with various laboratories and equipment. This software facilitates FinTech integration and features tight API endpoints, allowing healthcare institutions to utilize the platform from any device and location. Additionally, Dashlabs.ai enables real-time tracking of specimens, which further supports efficient healthcare delivery.

Gradia Health

Pre Seed Round in 2021
We help clinics improve throughput by sending timely information to patients' phones. For example, we send colonoscopy patients handcrafted instructions to help them arrive at the GI clinic prepared.

MedMe

Seed Round in 2021
MedMe Health is a patient care platform that assists pharmacists in scheduling, conducting, and tracking clinical services both virtually and on-site. The platform employs proprietary algorithms to streamline various medical services, including online scheduling, digital diagnosis, documentation filing, and automated follow-up appointments. By facilitating these processes, MedMe Health enables pharmacies to enhance their workflows, strengthen patient relationships, and diversify revenue opportunities within clinical services.

Axle Health

Pre Seed Round in 2021
Axle Health enables telehealth companies, hospitals, insurance companies, and researchers to send nurses to their patients’ homes to administer physical services like blood draws and injections. Instead of going into a lab or doctor’s office, patients can now receive basic services at home.

Neurolytic Healthcare Ltd.

Seed Round in 2021
Neurolytic Healthcare Ltd. is a company based in Oxford, United Kingdom, specializing in the design, development, manufacturing, and delivery of digital and genomic-based diagnostic tools and medical devices aimed at treating migraine and related neurological disorders. Established in 2016, the company focuses on personalized medicine by integrating genetic and biomarker data to enhance diagnostic accuracy and assist clinicians in determining optimal treatment strategies. Its product offerings include a diagnostic support tool, a pharmacogenetic test, and a mobile application designed for predicting migraine events. Through these innovative solutions, Neurolytic Healthcare aims to improve the management and treatment of neurological conditions.

H1

Series B in 2020
H1 is the developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

Kenota Health

Series A in 2020
Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.

FidoCure

Series A in 2020
The One Health Company is a social impact company that brings precision medicine, used in humans, to dogs with cancer. It started by offering dogs with cancer access to cutting edge human clinical trials at no cost. Then, they created FidoCure directly for veterinarians and pet parents to offer treatment options to more dogs across the country. The company built partnerships with the world's top cancer researchers and a network of 111 of the best veterinary hospitals.

Biocogniv

Pre Seed Round in 2020
Biocogniv Inc. specializes in developing artificial intelligence-powered diagnostic tools tailored for hospitals. Founded in 2019 and based in Burlington, Vermont, the company creates plugins for electronic health records (EHRs) that enhance clinical decision-making. Its initial product screens patients for COVID-19 by rapidly analyzing standard blood test results, achieving a sensitivity rate of 95%. Additionally, Biocogniv's technology aims to predict sepsis-related in-hospital mortality and the need for intensive care unit admission during emergency department visits. By seamlessly integrating with EHR workflows, Biocogniv's solutions facilitate accurate and non-invasive diagnostic methods, thereby improving patient outcomes and operational efficiency in the medical sector.

RingMD

Seed Round in 2020
RingMD is a revolutionary healthcare communications platform that grants people access to quality and affordable healthcare - all across the globe. Through their website or mobile app, people can connect with world-class physicians - wherever they are. Patients schedule a consultation in one minute and choose how to communicate. At their convenience, they can connect with a doctor via video, audio, or secure messaging. All from the comfort of their own home or on the go.

Daybreak Health

Seed Round in 2020
Daybreak Health Inc. provides evidence based online counseling services for teens that focuses on achievement pressure, stress, social isolation, self-esteem, anxiety, and depression. The company provides individual counseling, group sessions , and wellbeing tools through its mobile app. Daybreak Health Inc. was formerly known as Elemental Health Inc. The company founded in 2020 and is based in San Francisco, California.

Liyfe

Seed Round in 2020
Liyfe is a remote symptom management and telemedicine platform that focuses on cancer diagnosis, treatment, and related resources. It employs an AI-based digital nurse chatbot to facilitate personalized triage pathways, enhancing patient care. Liyfe offers membership programs, allowing patients to access unlimited communication with nurse practitioners via text messaging for a monthly fee equivalent to a co-pay. This service provides on-demand virtual care 24/7 through HIPAA-compliant text and video chat. Additionally, the platform features a user-friendly electronic medical records (EMR) system, enabling patients to efficiently archive their medical records.

Biocogniv

Pre Seed Round in 2020
Biocogniv Inc. specializes in developing artificial intelligence-powered diagnostic tools tailored for hospitals. Founded in 2019 and based in Burlington, Vermont, the company creates plugins for electronic health records (EHRs) that enhance clinical decision-making. Its initial product screens patients for COVID-19 by rapidly analyzing standard blood test results, achieving a sensitivity rate of 95%. Additionally, Biocogniv's technology aims to predict sepsis-related in-hospital mortality and the need for intensive care unit admission during emergency department visits. By seamlessly integrating with EHR workflows, Biocogniv's solutions facilitate accurate and non-invasive diagnostic methods, thereby improving patient outcomes and operational efficiency in the medical sector.

Known Medicine

Seed Round in 2020
Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.

SiPhox Inc.

Seed Round in 2020
SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests for disease safely and in a disposable point-of-care and at-home manner. SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.

Endpoint Health

Venture Round in 2020
Endpoint Health, Inc. researches and develops therapies by combining therapeutics, companion diagnostics, and artificial intelligence into an integrated platform. It develops therapies to improve the outcomes of patients with critical illnesses, such as sepsis, acute respiratory distress syndrome, and COVID-19. Endpoint Health, Inc. was founded in 2018 and is headquartered in Palo Alto, California. It has additional offices in Detroit and Livonia, Michigan; and Chicago, Illinois.

Helium Health

Series A in 2020
Helium Health is a technology company focused on transforming healthcare in Africa through its electronic health records and hospital management systems. Founded in 2016 and headquartered in Lagos, Nigeria, the company provides a comprehensive suite of software tools designed to digitize medical records, manage hospital operations, and facilitate financial applications. Its platform features capabilities for managing patient visits, prescriptions, billing, and telemedicine solutions, all accessible from various devices. Additionally, Helium Health offers functionalities such as customizable forms, smart analytics, appointment management, and alerts, which help healthcare providers enhance efficiency, improve patient care, and reduce operational waste. By leveraging technology, Helium Health aspires to become the leading healthcare data exchange in Africa.

54gene

Series A in 2020
54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.

Darmiyan

Seed Round in 2020
Darmiyan, Inc. develops a commercial diagnostic software platform for the early detection, monitoring, and stratification of Alzheimer’s disease and other neurodegenerative. It offers BrainSee, a Software as a Service (SaaS) platform that analyzes the scans and provides detailed brain maps with quantification of neurodegeneration in each voxel, as well as a summary score that reflects the person’s brain health and the likelihood of future cognitive decline. The company’s BrainSee is a virtual microscope of the human brain that takes standard clinical brain MRI and basic cognitive tests and generates brain maps and scores that indicate pathology at the earliest stages of the disease when treatments are feasible. The company was founded in 2014 and is based in San Francisco, California.

H1

Series A in 2020
H1 is the developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

Healthlane

Pre Seed Round in 2020
Healthlane is a healthcare technology company that operates an online application aimed at enhancing access to quality and affordable healthcare services in Africa. Established in 2020 and headquartered in Lagos, Nigeria, with additional offices in Yaounde, Cameroon, and San Francisco, California, the platform facilitates users in tracking medical appointments and consolidating their health data. It offers features such as virtual medical advice on various health topics, including pregnancy, vaccinations, lab results, family planning, and insurance records. By enabling direct communication with certified doctors, Healthlane empowers individuals to make informed health decisions and efficiently monitor their health status.

Newman's

Seed Round in 2020
Newman's is Indonesia's Digital Health Clinic for men. Our platform allows customers to consult specialist doctors anytime and from any where and get their proven treatments delivered right to their doorsteps for free.

Loop Health

Seed Round in 2020
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.

Jeevam Health

Pre Seed Round in 2020
Jeevam Health is an Online Medical Clinic to Cure Root Cause of Chronic Issues in India. Jeevam Health is creating the treatment for patients suffering from chronic issues to reverse their conditions. It's a personalized, whole-body approach to medical care driven by functional medicine doctors.

H1

Seed Round in 2020
H1 is the developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

Wingspan Health

Grant in 2019
We bring all of your medical information into one place - automatically - so you can see a full picture of your health and healthcare.

Scanwell Health

Seed Round in 2019
Scanwell Health, Inc. is a healthcare company that specializes in designing and developing urine testing kits. The primary product, a urinary tract infection test kit, enables users to obtain clinical-grade results through their smartphones. In addition to test results, the kit connects users with an online doctor’s office for same-day treatment and prescription services. Established in 2018 and headquartered in Los Angeles, California, Scanwell Health has received FDA clearance for its urine testing application, underscoring its commitment to providing accessible and reliable healthcare solutions.

Digi-Prex

Seed Round in 2019
Digi-Prex operates a monthly medication delivery platform that focuses on serving patients with chronic diseases in India. Founded in 2019 and headquartered in Hyderabad, with an additional office in San Francisco, the company enables patients to upload prescriptions and receive their medications at discounted rates from local pharmacies. In addition to medication delivery, Digi-Prex offers a comprehensive management solution tailored to individual health needs, providing a one-stop platform for chronic disease management. This approach aims to simplify access to necessary treatments while supporting patients in effectively managing their health conditions.

Shift Health

Seed Round in 2019
Shift Health develops a healthcare revenue cycle technology designed with transparency. The company is working to improve the patient payment experience with increased transparency and clarity regarding their financial obligations. In turn, this benefits providers which, through the systems, can now increase collections and patient satisfaction all while eliminating costs and streamlining processes.

Palifer

Seed Round in 2019
Palifer is a data intelligence company that specializes in predictive maintenance, particularly for trains and healthcare inquiries. By leveraging artificial intelligence and natural language processing, Palifer efficiently integrates and organizes diverse data sources without the need for human intervention. Its platform not only predicts potential equipment failures and maintenance needs but also offers users immediate answers to health-related questions. Through a user-friendly web interface, Palifer engages individuals by asking targeted questions about their symptoms, thereby providing personalized insights and guiding them toward appropriate medical action or reassurance. This dual focus allows Palifer to support both transportation and healthcare sectors, enhancing operational efficiency and improving user experiences.

Probably Genetic

Seed Round in 2019
Probably Genetic is on a mission to help get answers for those with rare genetic conditions that are commonly initially diagnosed as autism spectrum disorder. On average, a patient with a rare genetic condition waits up 7 years to find answers. In the meantime, they spend years bouncing around from doctors to specialists, often at an enormous personal financial cost, to understand if there is more to their, or their child's symptoms. They believe this is too long! Probably Genetic offers educational material and DNA sequencing tests to make it easy to find out if there is more to your symptoms. Their aim is to help those who fall through the cracks of the current healthcare system.

Instapath

Seed Round in 2019
Instapath Inc. specializes in designing and developing a microscopy system that enhances the evaluation of cancer biopsies. The company’s technology allows for imaging biopsy samples at subcellular resolution immediately after removal, while also preserving the tissue for future analysis. This innovation aims to address a critical need, as over 7 million Americans undergo biopsy procedures annually, with a significant portion failing to provide accurate diagnoses, leading to costly repeat procedures. By improving rapid on-site evaluation of biopsies, Instapath’s system reduces the necessity for these repeat procedures, thereby increasing operating room efficiency and potentially boosting hospital revenue. Founded in 2017, Instapath is headquartered in New Orleans, Louisiana.

Lucira Health

Series B in 2019
Lucira Health develops a new class of professional and home-health solutions to help illuminate and elucidate health status to expedite decision-making and treatment. The company's at-home test kit is well suited for home use and the molecular nucleic acid amplification technology is adaptable to COVID-19 detection. Lucira Health produces inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world. It enables consumers to take the first step in their healthcare management through at-home diagnosis and a companion mobile app to provide follow up treatment. Lucira Health was founded in 2013 and is headquartered in Emeryville, California, United States.

Digi-Prex

Seed Round in 2019
Digi-Prex operates a monthly medication delivery platform that focuses on serving patients with chronic diseases in India. Founded in 2019 and headquartered in Hyderabad, with an additional office in San Francisco, the company enables patients to upload prescriptions and receive their medications at discounted rates from local pharmacies. In addition to medication delivery, Digi-Prex offers a comprehensive management solution tailored to individual health needs, providing a one-stop platform for chronic disease management. This approach aims to simplify access to necessary treatments while supporting patients in effectively managing their health conditions.

54gene

Seed Round in 2019
54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.

Unima

Seed Round in 2019
Unima developed a fast and low cost diagnostic and disease surveillance technology for low resource settings. This technology allows anyone, even those with no technical training, to diagnose a disease at the point of care, without the need of lab equipment, with results on 15 minutes and at $1 per test. The company's goal is to solve the problem of lack of access to timely diagnostic regardless of where you live and your ability to pay.

AIRx Health

Seed Round in 2019
AIRx Health, Inc., a digital healthcare company, develops and operates a platform that connects patients to medical teams for remote patient monitoring for COPD, hypertension, stroke, and COVID-19. The company was founded in 2019 and is based in San Jose, California.

54gene

Seed Round in 2019
54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.

Brick Health

Pre Seed Round in 2019
Brick Health operates as a provider of in-person medical services designed to enhance the quality and accessibility of virtual primary care. The company offers a range of services, including diagnostics, nursing support, point-of-care testing, and phlebotomy, all at transparent cash prices. By bridging the gap between telemedicine and traditional in-person care, Brick Health aims to ensure that patients utilizing virtual clinics have access to essential medical services at affordable rates.

Probably Genetic

Pre Seed Round in 2019
Probably Genetic is on a mission to help get answers for those with rare genetic conditions that are commonly initially diagnosed as autism spectrum disorder. On average, a patient with a rare genetic condition waits up 7 years to find answers. In the meantime, they spend years bouncing around from doctors to specialists, often at an enormous personal financial cost, to understand if there is more to their, or their child's symptoms. They believe this is too long! Probably Genetic offers educational material and DNA sequencing tests to make it easy to find out if there is more to your symptoms. Their aim is to help those who fall through the cracks of the current healthcare system.

Stack Diagnostics

Pre Seed Round in 2019
Stack Diagnostics is a hospital & health care that improves the application of genomics and AI in the diagnosis and treatment of people. It also provides genetic testing services in the clinical setting and directly to consumers at affordable prices. It was founded in 2018 and is headquartered in Delaware, USA.

Centaur Labs

Pre Seed Round in 2019
Our platform uses trained professionals to analyze medical images and videos, enabling our customers to build new technologies and treatments to detect and fight disease.

Instapath

Seed Round in 2019
Instapath Inc. specializes in designing and developing a microscopy system that enhances the evaluation of cancer biopsies. The company’s technology allows for imaging biopsy samples at subcellular resolution immediately after removal, while also preserving the tissue for future analysis. This innovation aims to address a critical need, as over 7 million Americans undergo biopsy procedures annually, with a significant portion failing to provide accurate diagnoses, leading to costly repeat procedures. By improving rapid on-site evaluation of biopsies, Instapath’s system reduces the necessity for these repeat procedures, thereby increasing operating room efficiency and potentially boosting hospital revenue. Founded in 2017, Instapath is headquartered in New Orleans, Louisiana.

Inito

Pre Seed Round in 2019
Inito is the world’s first comprehensive at-home diagnostics device that allows diagnostic tests for fertility, diabetes, vitamins, thyroid and dozens more on a single device connected to a smartphone. By collecting data about your body, our App provides personalized insights, treatments and lifestyle modifications to help millions of people become healthier and get back to living the lives they dream about. Inito is backed by the best investors in the world – Y Combinator and many others in US, Singapore & India.

FidoCure

Seed Round in 2019
The One Health Company is a social impact company that brings precision medicine, used in humans, to dogs with cancer. It started by offering dogs with cancer access to cutting edge human clinical trials at no cost. Then, they created FidoCure directly for veterinarians and pet parents to offer treatment options to more dogs across the country. The company built partnerships with the world's top cancer researchers and a network of 111 of the best veterinary hospitals.

Data Driven Bioscience

Seed Round in 2018
Data Driven Bioscience is a company based in Durham, North Carolina, that specializes in providing integrated kits and software designed for cancer diagnosis. Their products enable clinical laboratories to utilize genomics in the diagnosis and treatment of cancer. The kits are equipped to connect with machine learning software and a comprehensive database of cancer cases, allowing for the generation of detailed molecular reports for individual tumors. This innovative approach aims to enhance the accuracy and effectiveness of cancer diagnostics, facilitating better treatment decisions for patients.

FidoCure

Seed Round in 2018
The One Health Company is a social impact company that brings precision medicine, used in humans, to dogs with cancer. It started by offering dogs with cancer access to cutting edge human clinical trials at no cost. Then, they created FidoCure directly for veterinarians and pet parents to offer treatment options to more dogs across the country. The company built partnerships with the world's top cancer researchers and a network of 111 of the best veterinary hospitals.

EpiFluid

Seed Round in 2018
EpiFluid develops ways to detect the early stage of Alzheimer's disease using cfDNA testing.

Scanwell Health

Seed Round in 2018
Scanwell Health, Inc. is a healthcare company that specializes in designing and developing urine testing kits. The primary product, a urinary tract infection test kit, enables users to obtain clinical-grade results through their smartphones. In addition to test results, the kit connects users with an online doctor’s office for same-day treatment and prescription services. Established in 2018 and headquartered in Los Angeles, California, Scanwell Health has received FDA clearance for its urine testing application, underscoring its commitment to providing accessible and reliable healthcare solutions.

Inito

Pre Seed Round in 2018
Inito is the world’s first comprehensive at-home diagnostics device that allows diagnostic tests for fertility, diabetes, vitamins, thyroid and dozens more on a single device connected to a smartphone. By collecting data about your body, our App provides personalized insights, treatments and lifestyle modifications to help millions of people become healthier and get back to living the lives they dream about. Inito is backed by the best investors in the world – Y Combinator and many others in US, Singapore & India.

Coral Genomics

Seed Round in 2018
Coral Genomics generates novel data sets to fill gaps in large-scale biobanks with clinical diagnostics that facilitate medication selection for diverse populations. Integrating molecular, functional, and clinical factors to optimize treatment for chronic disease, Coral works with healthcare systems to provide end-to-end precision medicine support from next-generation sequencing through patient/provider facing healthcare reports that create more personalized and efficient healthcare delivery.

Elemeno Health

Seed Round in 2017
Elemeno Health, Inc. develops and offers mobile software for hospitals to eliminate medical errors. It provides a checklist tool for frontline healthcare teams in hospitals and medical centers. Elemeno Health, Inc. is based in the United States.

Helium Health

Seed Round in 2017
Helium Health is a technology company focused on transforming healthcare in Africa through its electronic health records and hospital management systems. Founded in 2016 and headquartered in Lagos, Nigeria, the company provides a comprehensive suite of software tools designed to digitize medical records, manage hospital operations, and facilitate financial applications. Its platform features capabilities for managing patient visits, prescriptions, billing, and telemedicine solutions, all accessible from various devices. Additionally, Helium Health offers functionalities such as customizable forms, smart analytics, appointment management, and alerts, which help healthcare providers enhance efficiency, improve patient care, and reduce operational waste. By leveraging technology, Helium Health aspires to become the leading healthcare data exchange in Africa.

Koko

Seed Round in 2017
Totemic makes a device to monitor the health and safety of older adults in a completely passive way--with no wearables required. We are solving the problem of how society will take care of 50m+ older adults in the US in a scalable & humane manner. They can monitor the most salient pieces of information in an older adult's day to day: serious health events like falls, behavioral red flags such as changes in urination frequency, skipping meals, or being bedridden which can all correlate with health decline.

Athelas

Seed Round in 2017
Athelas, Inc. develops and manufactures an innovative in-home blood diagnostic device designed to monitor the immune system using just a drop of blood. Founded in 2016 and based in Mountain View, California, the company's portable optical unit analyzes blood cells and generates diagnostic reports. This technology assists healthcare providers in early identification of conditions such as leukemia, infections, and inflammatory diseases, allowing patients to monitor their immunity levels conveniently from home. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

Oncobox

Seed Round in 2017
OncoBox is cost-effective personalized genetic profiling to help doctors decide which drug to use in late-stage cancer patients. OncoBox analyzes the molecular characteristics of a particular tumor and calculates the probability of a positive effect using specific cancer drugs.

Darmiyan

Pre Seed Round in 2017
Darmiyan, Inc. develops a commercial diagnostic software platform for the early detection, monitoring, and stratification of Alzheimer’s disease and other neurodegenerative. It offers BrainSee, a Software as a Service (SaaS) platform that analyzes the scans and provides detailed brain maps with quantification of neurodegeneration in each voxel, as well as a summary score that reflects the person’s brain health and the likelihood of future cognitive decline. The company’s BrainSee is a virtual microscope of the human brain that takes standard clinical brain MRI and basic cognitive tests and generates brain maps and scores that indicate pathology at the earliest stages of the disease when treatments are feasible. The company was founded in 2014 and is based in San Francisco, California.

PreDxion Bio

Seed Round in 2017
PreDxion Bio is a precision medicine diagnostics company that provides ICU doctors with actionable patient immune function data. The company offers MicroKine, a diagnostic tool that measures patients’ immune responses. It enables doctors to identify up to six cytokine proteins using small blood volumes. Using this technology, physicians are able to tailor ICU treatments to each patient's needs. Founded in 2016, PreDxion Bio is based in Ann Arbor, Michigan.

Helium Health

Seed Round in 2017
Helium Health is a technology company focused on transforming healthcare in Africa through its electronic health records and hospital management systems. Founded in 2016 and headquartered in Lagos, Nigeria, the company provides a comprehensive suite of software tools designed to digitize medical records, manage hospital operations, and facilitate financial applications. Its platform features capabilities for managing patient visits, prescriptions, billing, and telemedicine solutions, all accessible from various devices. Additionally, Helium Health offers functionalities such as customizable forms, smart analytics, appointment management, and alerts, which help healthcare providers enhance efficiency, improve patient care, and reduce operational waste. By leveraging technology, Helium Health aspires to become the leading healthcare data exchange in Africa.

Koko

Pre Seed Round in 2017
Totemic makes a device to monitor the health and safety of older adults in a completely passive way--with no wearables required. We are solving the problem of how society will take care of 50m+ older adults in the US in a scalable & humane manner. They can monitor the most salient pieces of information in an older adult's day to day: serious health events like falls, behavioral red flags such as changes in urination frequency, skipping meals, or being bedridden which can all correlate with health decline.

MDacne

Seed Round in 2017
MDacne mission is to disrupt the old physician-centric medical system and put the patient in the center. Using smart algorithms and computer vision to provide real-time mobile tools for people with health disorders. The company's first mobile app, MDacne, targets 500 million people suffering from Acne and provides them an immediate self-diagnosis personalized treatment plan in order to treat their Acne and enhance their quality of life.

Pulse

Seed Round in 2017
Pulse provides online medical records.

AlemHealth

Seed Round in 2017
AlemHealth Pte. Ltd. is a Singapore-based company that specializes in designing and manufacturing digital healthcare solutions aimed at mitigating global doctor shortages. Founded in 2015, AlemHealth offers innovative products such as AlemBox, which connects hospitals to a global network of physicians and their patient data, and AlemDoc, a cloud-based application that facilitates access and transfer of patient data in bandwidth-limited environments. The company also develops teleradiology software and hardware that enables the storage, sharing, viewing, and reporting of medical imaging studies, utilizing advanced technologies like artificial intelligence and secure cloud storage. AlemHealth's solutions are tailored for frontier markets, promoting cross-border collaboration among physicians and ensuring that patients receive high-quality care at affordable prices.

InnaMed

Angel Round in 2017
InnaMed is developing a comprehensive care management platform. ​ Our team is developing an at-home blood testing device and remote monitoring software that enable patients to easily communicate quantitative and qualitative health assessments from home. The collected data feeds into algorithms that detect deterioration early and guide treatment decisions, improving outcomes and reducing costs. We are focusing on chronic conditions starting with heart failure, kidney failure and post-transplant care.

Nephrogen

Seed Round in 2017
Nephrogen is a biotechnology company dedicated to developing novel diagnostics and research tools for various life threatening diseases.

Athelas

Seed Round in 2017
Athelas, Inc. develops and manufactures an innovative in-home blood diagnostic device designed to monitor the immune system using just a drop of blood. Founded in 2016 and based in Mountain View, California, the company's portable optical unit analyzes blood cells and generates diagnostic reports. This technology assists healthcare providers in early identification of conditions such as leukemia, infections, and inflammatory diseases, allowing patients to monitor their immunity levels conveniently from home. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

Kenota Health

Seed Round in 2016
Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.

Luminostics, Inc.

Seed Round in 2016
Luminostics, Inc. develops a smartphone-based adaptor to access molecular-level health information through 15-minute DIY disease testing. It serves healthcare professionals and consumers. The company was incorporated in 2015 and is based in Houston, Texas.

Kenota Health

Seed Round in 2016
Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.

Elemeno Health

Seed Round in 2016
Elemeno Health, Inc. develops and offers mobile software for hospitals to eliminate medical errors. It provides a checklist tool for frontline healthcare teams in hospitals and medical centers. Elemeno Health, Inc. is based in the United States.

PhysioHealth

Pre Seed Round in 2016
PhysioHealth is an enterprise health and wellness management platform that rewards your employees for living healthy and decreases your healthcare costs. Their customized platform delivers 5x engagement vs. other corporate wellness programs.

Luminist

Seed Round in 2016
Luminist, Inc. is a Newark, California-based company that focuses on developing a diagnostic platform for the early detection of liver disease. Founded in 2015, Luminist aims to provide a rapidly scalable and low-cost solution for screening various diseases, including liver conditions and cancer, through a data-driven approach. The company's technology transforms biochemical data into crucial health information, allowing patients to receive insights from a single test. Luminist operates as a subsidiary of DiscernDx.

X-ZELL

Seed Round in 2016
X-Zell, Inc. develops technology that detects cancer from a simple blood test in a laboratory. The company was incorporated in 2014 and is based in Wilmington, Delaware.

iSono Health

Pre Seed Round in 2016
iSono Health, Inc. is a San Francisco-based company that specializes in breast health monitoring through a wearable solution. Established in 2014, the company focuses on enhancing breast cancer screening by integrating automated ultrasound technology with artificial intelligence. This innovative approach allows users to scan and track changes in their breast health, compare images over time, and receive real-time feedback. Additionally, the solution facilitates the sharing of these images with radiologists, thereby promoting accessible and personalized monitoring for women and their healthcare providers.

Able Health

Seed Round in 2016
Able Health is a cloud platform that automates the tracking and reporting processes of value-based programs to help physicians more on treatment rather than paperwork. The platform consolidates all pattern data that have been pulled from all health records and claims in order to calculate how much money is earned; tracks performance by contract with different insurance companies; simplifies reporting going out to insurance companies; provides compressed information to clinicians; and delivers feedback to physicians and clinic managers on how to improve performance. Able Health was launched by Steve Daniels and Rachel Katz in April 2015 and is based in San Francisco, California.

Unima

Seed Round in 2016
Unima developed a fast and low cost diagnostic and disease surveillance technology for low resource settings. This technology allows anyone, even those with no technical training, to diagnose a disease at the point of care, without the need of lab equipment, with results on 15 minutes and at $1 per test. The company's goal is to solve the problem of lack of access to timely diagnostic regardless of where you live and your ability to pay.

CrowdMed

Seed Round in 2015
CrowdMed, Inc. is a healthcare technology company based in San Francisco, California, established in 2012. It utilizes a prediction market platform to address complex medical issues by tapping into the collective intelligence of a network of medical detectives, which includes licensed physicians, medical students, and other healthcare professionals. This innovative approach allows CrowdMed to provide patients with potential diagnoses and solutions for undiagnosed or chronic symptoms that have eluded traditional medical practices. By combining the insights of numerous contributors, CrowdMed aims to deliver accurate and timely medical suggestions, thereby streamlining the healthcare process. The company seeks to become a trusted resource for millions of patients facing challenging medical conditions.

MicroHealth

Seed Round in 2015
MicroHealth empowers people with chronic conditions to live healthier lives and healthcare professionals to improve clinical outcomes by leveraging mobile technology and a social health network. Their mission is to shape the future of chronic care management by engaging patients, triggering positive behavior change, and connecting all care participants to make better health decisions.

X-ZELL

Pre Seed Round in 2015
X-Zell, Inc. develops technology that detects cancer from a simple blood test in a laboratory. The company was incorporated in 2014 and is based in Wilmington, Delaware.

Lucira Health

Seed Round in 2014
Lucira Health develops a new class of professional and home-health solutions to help illuminate and elucidate health status to expedite decision-making and treatment. The company's at-home test kit is well suited for home use and the molecular nucleic acid amplification technology is adaptable to COVID-19 detection. Lucira Health produces inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world. It enables consumers to take the first step in their healthcare management through at-home diagnosis and a companion mobile app to provide follow up treatment. Lucira Health was founded in 2013 and is headquartered in Emeryville, California, United States.

PicnicHealth

Seed Round in 2014
PicnicHealth is all about making medical records easy to access and using data to power the next frontier of medical research. We’re led by the belief that there’s power in medical information when it’s used well, and that every person has a right to their own theirs. And we've built award-winning machine learning to do it. How? PicnicHealth works directly with patients to give them the only tool anywhere that truly provides all of their medical records from any doctor or healthcare system in the US—in an easy-to-use, secure online dashboard. Not only that, but patients can choose to contribute their data to scientific research, which helps life sciences researchers accelerate breakthroughs in care. Researchers use this anonymized “real-world data” to understand how diseases are experienced by patients and treated by clinicians in the real world, going beyond the highly controlled setting of clinical trials. The goal is to create better treatments that can ultimately improve outcomes for patients. Whether you’re a scientist, engineer, or patient yourself, we’re looking for passionate people to join us in redefining an industry during our next stage of growth. To date we’ve helped tens of thousands of patients, partnered with some of the world’s largest biopharma companies, and raised more than $35M from Felicis Ventures, Amplify Partners, Foresite Capital, Refactor Capital, and Y Combinator.

SpringWit

Seed Round in 2014
Brain health and awareness

CrowdMed

Seed Round in 2013
CrowdMed, Inc. is a healthcare technology company based in San Francisco, California, established in 2012. It utilizes a prediction market platform to address complex medical issues by tapping into the collective intelligence of a network of medical detectives, which includes licensed physicians, medical students, and other healthcare professionals. This innovative approach allows CrowdMed to provide patients with potential diagnoses and solutions for undiagnosed or chronic symptoms that have eluded traditional medical practices. By combining the insights of numerous contributors, CrowdMed aims to deliver accurate and timely medical suggestions, thereby streamlining the healthcare process. The company seeks to become a trusted resource for millions of patients facing challenging medical conditions.